Literature DB >> 11929987

Imaging the progression of Alzheimer pathology through the brain.

A David Smith1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11929987      PMCID： PMC123611          DOI： 10.1073/pnas.082107399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  35 in total

1.  Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease.

Authors:  L de Toledo-Morrell; B Dickerson; M P Sullivan; C Spanovic; R Wilson; D A Bennett
Journal:  Hippocampus       Date:  2000       Impact factor: 3.899

2.  Progression of corpus callosum atrophy in Alzheimer disease.

Authors:  Stefan J Teipel; Wolfram Bayer; Gene E Alexander; York Zebuhr; Diane Teichberg; Luka Kulic; Marc B Schapiro; Hans-Jürgen Möller; Stanley I Rapoport; Harald Hampel
Journal:  Arch Neurol       Date:  2002-02

3.  Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Authors:  Sudha Seshadri; Alexa Beiser; Jacob Selhub; Paul F Jacques; Irwin H Rosenberg; Ralph B D'Agostino; Peter W F Wilson; Philip A Wolf
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

4.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

Authors:  C R Jack; R C Petersen; Y Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

5.  Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype.

Authors:  S D Moffat; C A Szekely; A B Zonderman; N J Kabani; S M Resnick
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

6.  Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study.

Authors:  K Meguro; C LeMestric; B Landeau; B Desgranges; F Eustache; J C Baron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

Review 7.  Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization.

Authors:  T Arendt
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

8.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort.

Authors:  M F Elias; A Beiser; P A Wolf; R Au; R F White; R B D'Agostino
Journal:  Arch Neurol       Date:  2000-06

9.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Authors:  B T Hyman; G W Van Hoesen; A R Damasio; C L Barnes
Journal:  Science       Date:  1984-09-14       Impact factor: 47.728

10.  Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.

Authors:  Rachael I Scahill; Jonathan M Schott; John M Stevens; Martin N Rossor; Nick C Fox
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205
View more
  58 in total

1.  Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors.

Authors:  Francesca Grassi; Eleonora Palma; Raffaella Tonini; Mascia Amici; Marc Ballivet; Fabrizio Eusebi
Journal:  J Physiol       Date:  2003-01-17       Impact factor: 5.182

2.  Inter-relationships among diet, obesity and hippocampal-dependent cognitive function.

Authors:  T L Davidson; S L Hargrave; S E Swithers; C H Sample; X Fu; K P Kinzig; W Zheng
Journal:  Neuroscience       Date:  2013-08-30       Impact factor: 3.590

Review 3.  Multiple sclerosis and Alzheimer disease through the looking glass of MR imaging.

Authors:  Giovanni B Frisoni; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

4.  miR-146a Dysregulates Energy Metabolism During Neuroinflammation.

Authors:  Sujung Jun Kim; Ashley E Russell; Wei Wang; Darren E Gemoets; Saumyendra N Sarkar; James W Simpkins; Candice M Brown
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-24       Impact factor: 4.147

5.  MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD.

Authors:  R S Desikan; B Fischl; H J Cabral; T L Kemper; C R G Guttmann; D Blacker; B T Hyman; M S Albert; R J Killiany
Journal:  Neurology       Date:  2008-07-30       Impact factor: 9.910

Review 6.  Neuroimaging outcomes in clinical trials in Alzheimer's disease.

Authors:  G B Frisoni; A Delacourte
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

Review 7.  An application of Pavlovian principles to the problems of obesity and cognitive decline.

Authors:  T L Davidson; C H Sample; S E Swithers
Journal:  Neurobiol Learn Mem       Date:  2013-07-22       Impact factor: 2.877

8.  GPR40 receptor agonist TAK-875 improves cognitive deficits and reduces β-amyloid production in APPswe/PS1dE9 mice.

Authors:  Chao Liu; Zhao-Yan Cheng; Qing-Peng Xia; Yu-Hui Hu; Chen Wang; Ling He
Journal:  Psychopharmacology (Berl)       Date:  2021-06-26       Impact factor: 4.530

Review 9.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

Review 10.  Novel MRI techniques in the assessment of dementia.

Authors:  Stefan J Teipel; Thomas Meindl; Lea Grinberg; Helmut Heinsen; Harald Hampel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.